LBRX earnings: real EPS beat/miss history, analyst consensus Buy, P/E -1.67. Updated 2026-07-23.
LB Pharmaceuticals Inc Common Stock (LBRX) Research Hub
LB Pharmaceuticals Inc Common Stock (LBRX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 44.63 USD (-6.38%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.67, market cap 1.01B. This hub links to the full technical, earnings and options research available for LBRX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 44.63 USD (-6.38%) |
| 52-week range | 27.7 USD – 50.16 USD |
| Trend regime | Range |
| 14-day RSI | 41.4 (Bearish) |
| Trailing P/E | -1.67 |
| Market cap | 1.01B |
| Dividend yield | 0.00% |
Available research for LBRX
Covered Call on LBRX: how it works, illustrative setup around the real 44.63 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on LBRX: how it works, illustrative setup around the real 44.63 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on LBRX: how it works, illustrative setup around the real 44.63 USD price, max profit/loss, breakeven and when to use it. Educational.
LBRX technical analysis: range, last 44.63 USD, RSI 41.4, 52w range 27.7 USD–50.16 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is LBRX in?
LB Pharmaceuticals Inc Common Stock (LBRX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is LBRX in an uptrend or downtrend?
As of 2026-09-11, LBRX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is LBRX's trailing P/E ratio?
LBRX's trailing P/E is -1.67, with a market cap of 1.01B. See the earnings research page for full valuation detail.